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While an outright cure or a preventive vaccine for HIV/
AIDS remain elusive, remarkable advances in HIV treat-
ment have been achieved over the past two decades.
Most significant among these advances is the develop-
ment of highly active antiretroviral therapy (HAART).
Available evidence increasingly supports the notion
that the viral load suppression achieved by HAART has
a preventive impact on the transmission of HIV. Hence,
expanding HAART coverage to all those in medical
need, represents a key strategy to not only decrease HIV
and AIDS related morbidity and mortality but also to
dramatically reduce HIV transmission by all routes.
In British Columbia, the expansion of HAART cover-
age has been associated with a substantial reduction in
HIV new diagnoses (Montaner et al, Lancet, August
18th 2010). The role of treatment as prevention has
now been formally incorporated within the UNAIDS
global AIDS control strategy, under the “Treatment 2.0”
initiative.
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